Pandemic and other exceptional-event risks, including COVID-19
First written in FY2020. 6 of 15 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2026-H1.
Hosoya Pyro-Engineering moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2020: 74 of 116 companies on the "Worse" side.
103 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「During the interim accounting period, there were no new business or other risks and no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
It states that there have been no new outbreaks or material changes regarding pandemic and abnormal-event risks, including those related to the novel coronavirus infectious disease. - FY2024-Q2RestatedAnnual report
「During the cumulative second-quarter period, there were no new business or other risks, and no material changes to the business or other risks described in the securities report for the previous fiscal year.」
It states that there have been no new outbreaks or material changes regarding pandemic and abnormal-event risks, including those related to the novel coronavirus infectious disease. - FY2024-Q1RestatedAnnual report
「During the six months ended [current first quarter], there was no emergence of new business or other risks, nor any material change in the business or other risks described in the annual securities report for the previous fiscal year.」
It states that there have been no new outbreaks or material changes regarding pandemic and abnormal-event risks, including those related to the novel coronavirus infectious disease. - FY2023-Q3RestatedAnnual report
「There have been no material changes to the assumptions, including the future spread and timing of the subsidence of COVID-19, disclosed under Additional Information in the previous fiscal year's annual securities report.」
The company has reconfirmed that there have been no material changes to its assumptions regarding the novel coronavirus infectious disease. - FY2023-Q2RestatedAnnual report
「There have been no material changes to the assumptions, including the future spread and timing of the subsidence of COVID-19, disclosed under Additional Information in the previous fiscal year's annual securities report.」
The company has reconfirmed that there have been no material changes to its assumptions regarding the novel coronavirus infectious disease. - FY2023-Q1MitigatedAnnual report
「During the cumulative first quarter under review, Japan's economy moved toward normalisation as restrictions on activity associated with the novel viral infectious disease were eased.」
The company explains that restrictions on activity associated with the infectious disease were eased and economic activity moved toward normalisation, indicating that the risk of restrictions on economic activity caused by the infectious disease through the previous fiscal year had eased in the external environment during the quarter under review. - FY2022MitigatedAnnual report
「Although it is difficult to predict how the novel coronavirus infectious disease will spread in the future or when it will subside, its impact on the Company's business activities during the fiscal year under review was limited.」
The company explains that, although the possibility of further spread of the infectious disease remains, its impact on business activities during the fiscal year under review was limited. - FY2022-Q3RestatedAnnual report
「The spread of the novel infectious disease originating in Wuhan, China, may affect our financial position and operating results depending on how the situation develops. We will continue to closely monitor changes in the situation and take appropriate action.」
The company has reconfirmed the possibility that the novel viral infectious disease may affect its financial position and operating results, as well as its policy of monitoring the situation closely and responding accordingly. It states that there have been no material changes. - FY2022-Q2MaterialisedAnnual report
「During the cumulative second quarter under review, Japan's economy showed signs of recovery as a result of government policies and other factors, although restrictions on socioeconomic activity continued because of the spread of the novel viral infectious disease.」
The continuing restrictions on socioeconomic activity caused by the spread of infectious diseases have affected operating results, including through declining sales of products aimed at private-sector customers. - FY2022-Q1MaterialisedAnnual report
「The spread of the novel infectious disease originating in Wuhan, China, may affect our financial position and operating results depending on how the situation develops. We will continue to closely monitor changes in the situation and take appropriate action.」
The continuing impact of the renewed spread of infectious diseases has emerged in the operating environment as a challenging economic climate and declining orders for chemical products aimed at private-sector customers. - FY2021MaterialisedAnnual report
「In the core pyrotechnic products business, the impact of the spread of infectious diseases on the market for products aimed at private-sector customers led to sluggish sales.」
The impact of the spread of infectious diseases materialised in full-year results as stagnation in the market for products aimed at private-sector customers and sluggish sales. - FY2021-Q3MaterialisedAnnual report
「In the pyrotechnic products business, although sales of chemical products newly ordered during the current fiscal year increased, net sales decreased from the previous fiscal year because delivery of a large contract was postponed to the fourth quarter and the market for products sold to private-sector customers stagnated due to the spread of infectious diseases.」
The impact of the spread of infectious diseases has continued to emerge as stagnation in the market for products aimed at private-sector customers and declining sales. - FY2021-Q2MaterialisedAnnual report
「The spread of the novel infectious disease originating in Wuhan, China, may affect our financial position and operating results depending on how the situation develops. We will continue to closely monitor changes in the situation and take appropriate action.」
The continuing impact of the spread of infectious diseases has become evident in operating results as sluggish sales growth for products aimed at private-sector customers. - FY2021-Q1MaterialisedAnnual report
「The spread of the novel infectious disease originating in Wuhan, China, may affect our financial position and operating results depending on how the situation develops. We will continue to closely monitor changes in the situation and take appropriate action. In addition, for private-sector products, business activity in Japan and overseas was disrupted by the spread of the infectious disease, and revenue fell below the same period of the previous year due in part to delivery schedules being extended to the second quarter and beyond.」
The impact of the novel infectious disease materialized not merely as a possibility but as extended delivery schedules and lower revenue for private-sector products. - FY2020First statedAnnual report
「If a pandemic such as the spread of COVID-19 or an exceptional event such as a large-scale natural disaster occurs on a scale beyond our expectations and makes business operations difficult, it may have a significant impact on our financial position and operating results.」
The company has identified as a new risk the possibility that the spread of COVID-19, large-scale natural disasters, or other events could make business operations difficult and affect its financial position and operating results.